Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Tralesinidase Alfa

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Worldsymposium Showcases Tralensidase Alfa For Sanfilippo
    Worldsymposium Showcases Tralensidase Alfa For Sanfilippo

    05 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260205292673/en/Long-Term-Data-Presented-at-the-22nd-Annual-WORLDSymposium-Highlights-Tralesinidase-Alfa-Enzyme-Replacement-Therapys-Potential-as-the-First-Disease-Modifying-Treatment-Option-for-Sanfilippo-Syndrome-Type-B-MPS-IIIB

    BUSINESSWIRE
    05 Feb 2026
    Share Share
    Spruce Bio Presents Data At 22nd Worldsymposium 2026
    Spruce Bio Presents Data At 22nd Worldsymposium 2026

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Spruce inks deal for BioMarin asset, plans 2026 approval filing
    Spruce inks deal for BioMarin asset, plans 2026 approval filing

    16 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/spruce-smartens-pipeline-deal-biomarin-asset-plans-2026-approval-filing

    FIERCE BIOTECH
    16 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.